文献
J-GLOBAL ID:202102225382018154
整理番号:21A0093556
OncoPDSS:個人レベルでの腫瘍学薬物療法のためのエビデンスに基づく臨床意思決定支援システム【JST・京大機械翻訳】
OncoPDSS: an evidence-based clinical decision support system for oncology pharmacotherapy at the individual level
著者 (30件):
Xu Quan
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Xu Quan
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Zhai Jin-Cheng
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Zhai Jin-Cheng
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Huo Cai-Qin
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Huo Cai-Qin
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Li Yang
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Li Yang
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Dong Xue-Jiao
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Dong Xue-Jiao
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Li Dong-Fang
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Li Dong-Fang
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Huang Ru-Dan
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Huang Ru-Dan
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Shen Chuang
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Shen Chuang
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Chang Yu-Jun
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Chang Yu-Jun
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Zeng Xi-Ling
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Zeng Xi-Ling
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Meng Fan-Lin
(School of Medicine, Tsinghua University, Beijing, P.R. China)
,
Yang Fang
(College of Marine Life Sciences, Ocean University of China, Qingdao, P.R. China)
,
Zhang Wan-Ling
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Zhang Wan-Ling
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Zhang Sheng-Nan
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Zhang Sheng-Nan
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Zhou Yi-Ming
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Zhou Yi-Ming
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
,
Zhang Zhi
(National Engineering Research Center for Beijing Biochip Technology, Beijing, P.R. China)
,
Zhang Zhi
(CapitalBio Corporation, Changping District, Beijing, P.R. China)
資料名:
BMC Cancer (Web)
(BMC Cancer (Web))
巻:
20
号:
1
ページ:
1-10
発行年:
2020年
JST資料番号:
U7305A
ISSN:
1471-2407
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)